Sun-Novo Pharmaceutical
Founded Year
2009Stage
IPO | IPODate of IPO
6/21/2021Missing: Sun-Novo Pharmaceutical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sun-Novo Pharmaceutical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Sun-Novo Pharmaceutical News
Nov 8, 2022
10/24 08/09 10/25/2022 EST Message : *Required fields Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621) agreed to acquire an unknown minority stake in Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership) and Liu Yujing on October 25, 2022. Under the terms, consideration will be paid in form of cash and shares.
Sun-Novo Pharmaceutical Frequently Asked Questions (FAQ)
When was Sun-Novo Pharmaceutical founded?
Sun-Novo Pharmaceutical was founded in 2009.
Where is Sun-Novo Pharmaceutical's headquarters?
Sun-Novo Pharmaceutical's headquarters is located at 1st Floor, Building 7, No. 79 Shuangying West Road, Beijing.
What is Sun-Novo Pharmaceutical's latest funding round?
Sun-Novo Pharmaceutical's latest funding round is IPO.
Who are the investors of Sun-Novo Pharmaceutical?
Investors of Sun-Novo Pharmaceutical include Wuhan Investment, GF Xinde Investment Management Co., Haida Bicheng, GF Qianhe, Jingxiang Capital and 12 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.